Xinhua Silk Road - Belt and Road Portal, China's silk road economic belt and 21st Century Maritime Silk Road Website Xinhua Silk Road - Belt and Road Portal, China's silk road economic belt and 21st Century Maritime Silk Road Website
Subscribe CustomBlackClose

Belt & Road Weekly Subscription Form

download_pop

Research ReportCustomBlackClose

The full edition of the report is available at Xinhua Silk Road Database. You can click the “Table of Content” to have a general understanding of it.

Click on the button below to create your account and get immediate access to thousands of articles.

Start a Free Trial

Xinhua Silk Road Database
Search result Sorting by relevance

  • Shipping industry decarbonization requires global wisdom for solutions, Drewry MD

    Decarbonization is a huge challenge for the shipping industry, and "all the brains in China and overseas" are needed to address the challenge, according to Tim Power, managing director (MD) of Drewry, a maritime consultancy in London.

    June26,2025


  • Innovation for cancer researchers and patients in eastern Germany

    Cancer patients can be treated with a new magnetic resonance linear accelerator (MR-Linac) at the National Center for Radiation Research in Oncology (OncoRay) in Dresden in the eastern German state of Saxony.

    June22,2022



  • Across China: French doctor uses Chinese robot to perform remote cancer surgery for patient in Morocco

    Using a Chinese-made robot, a French surgeon has made a significant medical advancement by performing a remote prostate cancer surgery for a patient in Morocco, who was 12,000 kilometers away.

    November25,2024


  • Amoy Diagnostics (300685.SZ): lung cancer detection product approved in Japan

    Amoy Diagnostics Co., Ltd. (300685.SZ) announced on Tuesday that its lung cancer detection product has been approved by the Pharmaceuticals and Medical Devices Agency (PMDA) of Japan, meaning that the product can be sold in the Japanese market.

    June30,2021


  • China's self-developed cancer drug approved in 50 markets

    Chinese biotechnology company BeiGene announced on Monday that its self-developed cancer drug, known as Brukinsa (zanubrutinib) in capsule form, was approved in Kuwait, Bahrain and Qatar for the treatment of adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy, reported China Securities Journal.

    June14,2022


  • Chinese company, IBM partner for better cancer treatment

    Baheal Pharm, a Chinese company that focuses on e-health, signed a partnership agreement with IBM in Beijing on Wednesday to introduce Watson for Genomics to medical institutions in China.

    June22,2017


  • China removes import tariffs on all cancer drugs

    China on Tuesday has exempted import tariffs on all common drugs including cancer drugs, cancer alkaloid-based drugs, and imported traditional Chinese medicine.

    May03,2018


  • UK to build cancer treatment centers in Iran

    Iran's Ministry of Health signed an investment and cooperation Memorandum of Understanding (MoU) with UK's International Hospitals Group (IHG), Financial Tribune daily reported on Tuesday.

    October25,2017


  • Yunnan cooperates with int'l medical resources to fight cancer

    An international forum on high-incidence tumor was held on Saturday in Kunming, capital of southwest China's Yunnan Province.

    July10,2018


  • Baheal Pharm to launch better cancer treatment technology with IBM help

    Baheal Pharm, a Chinese company that focuses on e-health, signed a partnership agreement with IBM in Beijing on Wednesday to introduce Watson for Genomics to medical institutions in China.

    June23,2017


  • Chinese company completes acquisition of U.S. firm providing immunotherapy for prostate cancer

    Sanpower Group, a private Chinese conglomerate, announced Friday the completion of its acquisition of Dendreon, from Valeant Pharmaceuticals International, Inc. for 819.9 million U.S. dollars in cash.

    July03,2017


  • Jing'an women's marathon to raise breast cancer awareness

    ​Nearly 4,000 people will take part in a running event to be held in Daning Park on March 17, Jing’an Sports Bureau said Friday.

    June19,2019


  • China to open AI cloud based cervical cancer diagnosis platform to the world

    China will open an artificial intelligence (AI) cloud based cervical cancer diagnosis platform to the world as of April to facilitate the cervical cancer screening worldwide.

    March29,2019


  • IBM's AI platform to help doctors diagnose cancer in N China

    IBM's artificial intelligence platform Watson in February will start to assist doctors at a North China general hospital who are offering people diagnosed with cancer a precise treatment.

    January18,2017


  • Chinese hospital offers free cervical cancer treatment to Zimbabwean women

    Zimbabwe's largest referral hospital has once again partnered China's Hunan Provincial Maternal Hospital in offering free cervical cancer screening and treatment to at least 1, 700 Zimbabwean women in 2019.

    May08,2019


  • NMS, the cancer research passes through the support of China and the stock exchange

    There is a listing on an important stock exchange like New York or Hong Kong in the future of the Nerviano group, 90% acquired in March 2018 by the Chinese of Hefei Sari V-Capital Management.

    December05,2019


  • GSK, INNOVAX and Xiamen University to jointly develop next-generation cervical cancer vaccine

    INNOVAX, a subsidiary of China's YangShengTang Group, and Xiamen University signed a global alliance partnership agreement on Friday with British pharmaceutical giant GlaxoSmithKline (GSK) in Wavre, Belgium, to develop a next-generation vaccine against human papillomavirus (HPV).

    September07,2019


  • ​New Horizon Health completes US$66 mln financing to promote early cancer screening service

    New Horizon Health, a Hangzhou-headquartered biotech company, announced late Friday that it has completed its Series C round of financing, securing 66 million US dollars from overseas investors to promote early cancer screening service.

    May27,2019


  • Chinese, Australian researchers unveil breakthrough imaging technology, revealing cellular secrets

    Chinese and Australian researchers have developed a groundbreaking imaging technology that could transform the study of cellular processes and provide insights into diseases such as cancer, neurodegenerative disorders, and metabolic conditions.

    April03,2025


  • Ask Us A Question belt & road login close

    If you have any questions, please enter them in the box below.

    Identifying code Reload

    Write to Us belt & road login close

    Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to silkroadweekly@xinhua.org and share your stories with more people.

    Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.

    Start a Free Trial